NCT05150691 2026-01-28A Phase 1/2a Study of DB-1303/BNT323 in Advanced/Metastatic Solid TumorsDualityBio Inc.Phase 1/2 Recruiting796 enrolled
NCT06256055 2024-07-24Phase 1 Study of UCMYM802 Injection in Mesothelin-positive Advanced Malignant Solid TumorsUTC Therapeutics Inc.Phase 1 Recruiting24 enrolled
NCT06043466 2023-09-21A Clinical Trial Targeting CEA Chimeric Antigen Receptor T (CAR-T) for CEA Positive Advanced Malignant Solid TumorsChongqing Precision Biotech Co., LtdPhase 1 Recruiting30 enrolled